|
|
减瘤性前列腺根治术临床预后分析
|
Abstract:
目前转移性前列腺癌(Metastatic prostate cancer, mPCa)患者标准治疗方式为内分泌治疗，此类患者临床预后较差，已有研究证明mPCa患者行减瘤性前列腺根治术(cytoreductive radical prostatectomy, CRP)可以延长患者生存期、减少并发症等，但对于此手术的可靠性及价值仍有待商榷。在我国，部分PCa患者确诊时已进入远处转移阶段，本文综合国内外研究对转移性前列腺癌患者行减瘤性手术的临床预后进行初步探讨。
Currently, the standard treatment for a patient with metastatic prostate cancer (mPCa) is endocrine therapy. In this case, the clinical prognosis is poor. It has been proved that cytoreductive radical prostatectomy (CRP) can prolong survival and reduce complications in mPCa patients, but the reliability and value of this surgery remain to be discussed. In our country, some PCa patients have entered the distant stage of metastasis when diagnosed. This paper preliminarily discusses the clinical prognosis of patients with metastatic prostate cancer undergoing tumor-reducing surgery based on domestic and foreign studies.
| [1] | Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Sta-tistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660 |
| [2] | Kimura, T. and Egawa, S. (2018) Epidemiology of Prostate Cancer in Asian Countries. International Journal of Urology: Official Journal of the Japanese Urological Association, 25, 524-531. https://doi.org/10.1111/iju.13593 |
| [3] | Ntatsis, K., Papantoni, E., Kyziridis, D., Kalakonas, A., Hristakis, C., Tzavara, C. and Tentes, A.A. (2021) Ovarian Cancer: 20-Year Experience with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. Journal of BUON, 26, 1754-1761. |
| [4] | Brand, A.H., DiSilvestro, P.A., Sehouli, J. and Berek, J.S. (2017) Cytoreductive Surgery for Ovarian Cancer: Quality Assessment. Annals of Oncology, 28, viii25-viii29. https://doi.org/10.1093/annonc/mdx448 |
| [5] | Méjean, A., Ravaud, A., Thezenas, S., et al. (2021) Sunitinib Alone or after Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Ne-phrectomy? European Urology, 80, 417-424.
https://doi.org/10.1016/j.eururo.2021.06.009 |
| [6] | Ljunggren, M., Nordenvall, C. and Palmer, G. (2021) Direct Surgery with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Colorectal Per-itoneal Metastases. European Journal of Surgical Oncology, 47, 2865-2872. https://doi.org/10.1016/j.ejso.2021.05.046 |
| [7] | Yin, J.J., Pollock, C.B. and Kelly, K. (2005) Mechanisms of Cancer Metastasis to the Bone. Cell Research, 15, 57-62.
https://doi.org/10.1038/sj.cr.7290266 |
| [8] | Kaplan, R.N., Psaila, B. and Lyden, D. (2006) Bone Marrow Cells in the “Pre-Metastatic Niche”: Within Bone and Beyond. Cancer and Metastasis Reviews, 25, 521-529. https://doi.org/10.1007/s10555-006-9036-9 |
| [9] | Zhang, X. (2019) Interactions between Cancer Cells and Bone Microenvironment Promote Bone Metastasis in Prostate Cancer. Cancer Communications (London), 39, 76. https://doi.org/10.1186/s40880-019-0425-1 |
| [10] | Clézardin, P., Coleman, R., Puppo, M., et al. (2021) Bone Me-tastasis: Mechanisms, Therapies, and Biomarkers. Physiological Reviews, 101, 797-855. https://doi.org/10.1152/physrev.00012.2019 |
| [11] | Coletta, A.M., Sayegh, N. and Agarwal, N. (2021) Body Com-position and Metastatic Prostate Cancer Survivorship. Cancer Treatment and Research Communications, 27, Article ID: 100322. https://doi.org/10.1016/j.ctarc.2021.100322 |
| [12] | Predina, J.D., Kapoor, V., Judy, B.F., et al. (2012) Cytoreduction Surgery Reduces Systemic Myeloid Suppressor Cell Populations and Restores Intratumoral Immuno-therapy Effectiveness. Journal of Hematology & Oncology, 5, 34.
https://doi.org/10.1186/1756-8722-5-34 |
| [13] | Cai, Z., Chen, W., Zhang, J. and Li, H. (2018) Androgen Receptor: What We Know and What We Expect in Castration-Resistant Prostate Cancer. International Urology and Nephrology, 50, 1753-1764.
https://doi.org/10.1007/s11255-018-1964-0 |
| [14] | Sow, Y., Sow, O., Fall, B., et al. (2019) Impact of Tumor Cytoreduction in Metastatic Prostate Cancer. Research and Reports in Urology, 11, 137-142. https://doi.org/10.2147/RRU.S204507 |
| [15] | Heidenreich, A., Fossati, N., Pfister, D., et al. (2018) Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases. European Urology Oncology, 1, 46-53. https://doi.org/10.1016/j.euo.2018.03.002 |
| [16] | Katelaris, N., Murphy, D., Lawrentschuk, N., Katelaris, A. and Moon, D. (2016) Cytoreductive Surgery for Men with Metastatic Prostate Cancer. Prostate International, 4, 103-106. https://doi.org/10.1016/j.prnil.2015.11.003 |
| [17] | Culp, S.H., Schellhammer, P.F. and Williams, M.B. (2014) Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study. European Urology, 65, 1058-1066.
https://doi.org/10.1016/j.eururo.2013.11.012 |
| [18] | Cheng, B., Ye, S. and Bai, P. (2021) The Efficacy of Cytoreductive Surgery for Oligometastatic Prostate Cancer: A Meta-Analysis. World Journal of Surgical Oncology, 19, 160. https://doi.org/10.1186/s12957-021-02265-8 |
| [19] | Fossati, N., Trinh, Q.D., Sammon, J., et al. (2015) Identi-fying Optimal Candidates for Local Treatment of the Primary Tumor among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-Based Study. European Urology, 67, 3-6.
https://doi.org/10.1016/j.eururo.2014.08.056 |
| [20] | Satkunasivam, R., Kim, A.E., Desai, M., et al. (2015) Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. Journal of Urology, 194, 378-385. https://doi.org/10.1016/j.juro.2015.02.084 |
| [21] | L？ppenberg, B., Dalela, D., Karabon, P., et al. (2017) The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis. European Urology, 72, 14-19.
https://doi.org/10.1016/j.eururo.2016.04.031 |
| [22] | Gratzke, C., Engel, J. and Stief, C.G. (2014) Role of Radical Prostatectomy in Metastatic Prostate Cancer: Data from the Munich Cancer Registry. European Urology, 66, 602-603. https://doi.org/10.1016/j.eururo.2014.04.009 |
| [23] | Lumen, N., De Bleser, E., Buelens, S., et al. (2021) The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-Volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry. European Urology Open Science, 29, 68-76. https://doi.org/10.1016/j.euros.2021.05.006 |
| [24] | Sweeney, C.J., Chen, Y.H., Carducci, M., et al. (2015) Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. The New England Journal of Medicine, 373, 737-746. https://doi.org/10.1056/NEJMoa1503747 |
| [25] | Babst, C., Amiel, T., Maurer, T., et al. (2022) Cytoreductive Radical Prostatectomy after Chemohormonal Therapy in Patients with Primary Metastatic Prostate Cancer. Asian Journal of Urology, 9, 69-74.
https://doi.org/10.1016/j.ajur.2021.04.003 |
| [26] | Pompe, R.S., Tilki, D., Preisser, F., et al. (2018) Survival Benefit of Local versus No Local Treatment for Metastatic Prostate Cancer-Impact of Baseline PSA and Metastatic Substages. Prostate, 78, 753-757.
https://doi.org/10.1002/pros.23519 |
| [27] | Liu, S., Wang, X.Y., Huang, T.B., et al. (2020) Effect on Survival of Local Treatment in Patients with Low Prostate-Specific Antigen, High Gleason Score Prostate Cancer: A Population-Based Propensity Score-Matched Analysis. Annals of Palliative Medicine, 9, 1708-1717. https://doi.org/10.21037/apm-19-414 |
| [28] | Heidenreich, A., Pfister, D. and Porres, D. (2015) Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study. Journal of Urology, 193, 832-838. https://doi.org/10.1016/j.juro.2014.09.089 |
| [29] | Gandaglia, G., Fossati, N., Stabile, A., et al. (2017) Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-Institution Series with Long-Term Follow-Up. European Urology, 72, 289-292.
https://doi.org/10.1016/j.eururo.2016.08.040 |
| [30] | Yaxley, J.W., Coughlin, G.D., Chambers, S.K., et al. (2016) Robot-Assisted Laparoscopic Prostatectomy versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study [Published Correction Appears in Lancet. 2017 Apr 8, 389(10077): e5]. The Lancet, 388, 1057-1066.
https://doi.org/10.1016/S0140-6736(16)30592-X |
| [31] | Basiri, A., de la Rosette, J.J., Tabatabaei, S., Woo, H.H., Laguna, M.P. and Shemshaki, H. (2018) Comparison of Retropubic, Laparoscopic and Robotic Radical Prostatectomy: Who Is the Winner? World Journal of Urology, 36, 609-621. https://doi.org/10.1007/s00345-018-2174-1 |
| [32] | Carbonara, U., Srinath, M., Crocerossa, F., et al. (2021) Ro-bot-Assisted Radical Prostatectomy versus Standard Laparoscopic Radical Prostatectomy: An Evidence-Based Analysis of Comparative Outcomes. World Journal of Urology, 39, 3721-3732. https://doi.org/10.1007/s00345-021-03687-5 |
| [33] | Stolzenburg, J.U., Holze, S., Neuhaus, P., et al. (2021) Robot-ic-Assisted Versus Laparoscopic Surgery: Outcomes from the First Multicentre, Randomised, Patient-Blinded Controlled Trial in Radical Prostatectomy (LAP-01). European Urology, 79, 750-759. https://doi.org/10.1016/j.eururo.2021.01.030 |
| [34] | Wagaskar, V.G., Mittal, A., Sobotka, S., et al. (2021) Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence without Compromising Surgical Margin Rates. European Urology, 80, 213-221.
https://doi.org/10.1016/j.eururo.2020.09.044 |
| [35] | Mazzone, E., Preisser, F., Nazzani, S., et al. (2019) The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes. European Urology Oncology, 2, 541-548. https://doi.org/10.1016/j.euo.2018.10.010 |
| [36] | Lestingi, J.F.P., Guglielmetti, G.B., Trinh, Q.D., et al. (2021) Ex-tended versus Limited Pelvic Lymph Node Dissection during Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. European Urology, 79, 595-604. https://doi.org/10.1016/j.eururo.2020.11.040 |
| [37] | Qu, M., Zhu, F., Chen, H., et al. (2019) Palliative Transurethral Resection of the Prostate in Patients with Metastatic Prostate Cancer: A Prospective Study of 188 Patients. Journal of Endourology, 33, 570-575.
https://doi.org/10.1089/end.2019.0108 |
| [38] | Qin, X.J., Ma, C.G., Ye, D.W., et al. (2012) Tumor Cytoreduction Results in Better Response to Androgen Ablation—A Preliminary Report of Palliative Transurethral Resection of the Prostate in Metastatic Hormone Sensitive Prostate Cancer. Urologic Oncology, 30, 145-149. https://doi.org/10.1016/j.urolonc.2010.02.010 |
| [39] | Rom, M., Waldert, M., Schatzl, G., Swietek, N., Shariat, S.F. and Klatte, T. (2014) Bladder Outlet Obstruction (BOO) in Men with Castration-Resistant Prostate Cancer. BJU Inter-national, 114, 62-66. https://doi.org/10.1111/bju.12438 |
| [40] | Seo, H.J., Lee, N.R., Son, S.K., Kim, D.K., Rha, K.H. and Lee, S.H. (2016) Comparison of Robot-Assisted Radical Prostatectomy and Open Radical Prostatectomy Outcomes: A Systematic Review and Meta-Analysis. Yonsei Medical Journal, 57, 1165-1177. https://doi.org/10.3349/ymj.2016.57.5.1165 |
| [41] | Lantz, A., Bock, D., Akre, O., et al. (2021) Functional and On-cological Outcomes after Open versus Robot-Assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-Up. European Urology, 80, 650-660.
https://doi.org/10.1016/j.eururo.2021.07.025 |
